Dr. John Ryan Cunningham, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 134 Menger Spgs Ste 1100, Boerne, TX 78006 Phone: 210-614-1234 Fax: 210-614-0952 |
News Archive
With reference to Chapter 4, Section 9 of the Swedish Financial Instruments Trading Act (SFS 1991:980), it is hereby announced that conversion of Series A stock units to Series B stock units during February 2010 has lead to the below changes in the number of stock units and votes in Artimplant AB.
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
Findings published today in The New England Journal of Medicine from a first-of-its-kind comparator trial evaluating the anti-tumor necrosis factor (TNF)-alpha biologic treatment REMICADE (infliximab) in the treatment of moderately to severely active Crohn's disease in patients who were naive to immunomodulator and biologic therapy, showed that a significantly greater proportion of patients receiving REMICADE achieved steroid-free remission and mucosal healing compared with patients receiving azathioprine.
People infected by the novel coronavirus can have symptoms that range from mild to deadly. Now, two new analyses suggest that some life-threatening cases can be traced to weak spots in patients' immune systems.
According to the U.S. Census Bureau, more than 74 million students will head back to school this fall, however, according to the National Youth Sports Safety Foundation (NYSSF), many of those students end up as part of the 15 million dental injuries and five million cases of traumatically lost teeth that occur every year.
› Verified 2 days ago